Prediction of cardiovascular and renal risk among patients with apparent treatment‐resistant hypertension in the United States using machine learning methods

by George Bakris, Pei (Paul) Lin, Chang Xu, Cindy Chen, Veronica Ashton, Mukul Singhal
Published 2024-05-01

Association of uncontrolled blood pressure in apparent treatment‐resistant hypertension with increased risk of major adverse cardiovascular events plus

by George Bakris, Cindy Chen, Alicia K. Campbell, Veronica Ashton, Lloyd Haskell, Mukul Singhal
Published 2023-08-01

Identification and Outcomes of Hospitalized Medically Ill Patients Who Are Candidates for Extended Duration Thromboprophylaxis

by Craig I. Coleman, Gregory Piazza, Veronica Ashton, Thomas J. Bunz, Alex C. Spyropoulos
Published 2020-10-01

Rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism in African American patients: a retrospective cohort analysis

by Olivia S. Costa, Stanley Thompson, Veronica Ashton, Michael Palladino, Thomas J. Bunz, Craig I. Coleman
Published 2020-04-01

Effectiveness and Safety of Rivaroxaban Versus Warfarin among Nonvalvular Atrial Fibrillation Patients with Concomitant Obstructive Sleep Apnea

by Nitesh Sood, Veronica Ashton, Youssef Bessada, Katelyn Galli, Brahim K. Bookhart, Craig I. Coleman
Published 2023-01-01

Occurrence of Thromboembolic Events and Mortality Among Hospitalized Coronavirus 2019 Patients: Large Observational Cohort Study of Electronic Health Records

by Alex C. Spyropoulos, James M. Crawford, Yen-Wen Cindy Chen, Veronica Ashton, Alicia K. Campbell, Dejan Milentijevic, W. Frank Peacock
Published 2022-10-01

Attainment of cholesterol target values in Greece: results from the Dyslipidemia International Study II

by Evangelos Liberopoulos, Loukianos Rallidis, Filio Spanoudi, Elena Xixi, Anselm Gitt, Martin Horack, Veronica Ashton, Philippe Brudi, Dominik Lautsch, Baishali Ambegaonkar, Moses Elisaf
Published 2018-03-01

Rivaroxaban Versus Warfarin for Management of Obese African Americans With Non-Valvular Atrial Fibrillation or Venous Thromboembolism: A Retrospective Cohort Analysis

by Olivia S. Costa PharmD, Jan Beyer-Westendorf MD, Veronica Ashton MPH, Dejan Milentijevic PhD, MBA, Kenneth Todd Moore MS, Thomas J. Bunz PharmD, PhD, Craig I. Coleman PharmD
Published 2020-10-01

Contemporary data on treatment practices for low-density lipoprotein cholesterol in 6794 patients with stable coronary heart disease across the world

by Anselm K. Gitt, Dominik Lautsch, Jean Ferrières, Gaetano M. De Ferrari, Ami Vyas, Carl A. Baxter, Lori D. Bash, Veronica Ashton, Martin Horack, Wael Almahmeed, Fu-Tien Chiang, Kian Keong Poh, Philippe Brudi, Baishali Ambegaonkar
Published 2018-06-01

Contemporary data on treatment practices for low-density lipoprotein cholesterol in 3867 patients who had suffered an acute coronary syndrome across the world

by Anselm K. Gitt, Dominik Lautsch, Jean Ferrières, Gaetano M. De Ferrari, Ami Vyas, Carl A. Baxter, Lori D. Bash, Veronica Ashton, Martin Horack, Wael Almahmeed, Fu-Tien Chiang, Kian Keong Poh, Philippe Brudi, Baishali Ambegaonkar
Published 2018-02-01

Real-World Analysis of Thromboembolic Events and Mortality of COVID-19 Outpatients in the United States

by W. Frank Peacock MD, FACEP, FACC, FESC, James M. Crawford MD, PhD, Yen-Wen (Cindy) Chen PhD, Veronica Ashton MPH, Alicia K. Campbell PharmD, Dejan Milentijevic PhD, MBA, Alex C. Spyropoulos MD, FACP, FCCP, FRCPC
Published 2022-08-01